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Abstract
The objective of this study was the application of the synthetic promoter library (SPL) technology for modulation of
actinorhodin production in Streptomyces coelicolor A3(2). The SPL technology was used to optimize the expression of a
pathway specific positive transcriptional regulator ActII orf4, which activates the transcription of the S. coelicolor
actinorhodin biosynthetic gene cluster. The native actII orf4 promoter was replaced with synthetic promoters, generating a
S. coelicolor library with a broad range of expression levels of actII orf4. The resulting library was screened based on the yield
of actinorhodin. Selected strains were further physiologically characterized. One of the strains from the library, ScoSPL20,
showed considerably higher yield of actinorhodin and final actinorhodin titer, compared to S. coelicolor wild type and S.
coelicolor with actII orf4 expressed from a strong constitutive promoter. ScoSPL20 demonstrated exceptional productivity
despite having a comparatively weak expression from the promoter. Interestingly, the ScoSPL20 promoter was activated at
a much earlier stage of growth compared to the wild type, demonstrating the advantage of fine-tuning and temporal
tuning of gene expression in metabolic engineering. Transcriptome studies were performed in exponential and
actinorhodin-producing phase of growth to compare gene expression between ScoSPL20 and the wild type. To our
knowledge, this is the first successful application of the SPL technology for secondary metabolite production in filamentous
bacteria.
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Introduction
Streptomycetes produce more than two thirds of all commer-
cially available antibiotics. They are soil-dwelling bacteria,
included in the taxonomic order Actinomycetales and have a
complex life cycle switching between the vegetative hyphae and
the spores. Streptomyces coelicolor A3(2) (WT) is the best characterized
member of the genus Streptomyces.
S. coelicolor produces four biochemically well characterized
antibiotics, namely a blue colored polyketide actinorhodin (ACT)
[1], undecylprodigiosin also known as RED [2], methylenomycin
[3] and a Ca-dependent antibiotic [4]. Production of these
antibiotics is regulated at different levels; the ACT biosynthesis
being the most studied one. ACT production has been shown to be
influenced by a number of genes involved in the morphological
differentiation (bld genes), as well as genes that have pleiotropic
effects (afs, rel, abs and dasR family of genes). Deletion or
overexpression of one of the fore-mentioned pleiotropic-effect
genes has been demonstrated to result in overproduction of ACT
[5,6,7,8]. Furthermore, the transcriptional regulator AtrA was
shown to directly bind to the promoter region of actII orf4 and
initiate ACT production [9]. Cyclic AMP receptor protein (Crp)
has been identified as a global regulator of secondary metabolism
by controlling production of precursors. The expression of six
secondary metabolic pathways in S. coelicolor was affected by Crp
and overexpression of Crp also led to increased antibiotic
production in other Streptomyces [10]. In addition, a pathway
specific regulator encoded by actII orf4 has been identified as a
positive regulator of the ACT gene cluster [11,12].
Various strategies of gene manipulation have been applied on
improving properties of industrial microorganisms. Most of these
approaches involve overexpression of genes encoding rate-limiting
enzymes or inactivation of competing branches of branched
pathways [13,14]. Such strategies have been fruitful in some cases
[15,16,17], but can fall short when discrete optimization of gene
expression is needed to fine-tune the modified pathway [18].
Promoter strength plays an important role in the resulting levels of
gene expression [14,19]. The synthetic promoter technology,
based on randomization of promoter sequences, has been
successfully employed to construct promoter libraries for opti-
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mized levels of gene expression [14,19,20]. To list a few examples,
the synthetic promoter library (SPL) approach has been used for
fine-tuning of expression of recombinant proteins in E. coli [21],
for metabolic engineering in Lactococcus lactis [22], for constitutive
gene expression in Lactobacillus plantarum [23] and for improving
lycopene production in S. cerevisiae [19]. Along similar lines,
Seghezzi et al. (2011) reported the construction of a generalized
synthetic promoter library in Streptomyces lividans [24].
The aim of our study was to investigate how modulation of
expression levels of the positive regulator actII orf4 affects ACT
production in S. coelicolor. In a benchmark strain, the expression of
actII orf4 was enhanced by constitutive overexpression (oxp) under
control of the promoter ermE*. In parallel, a SPL was constructed
based on the randomization of the sequences flanking the native
promoter of actII orf4, which enabled us to select a S. coelicolor A3(2)
strain with even higher yield and productivity of ACT than the
benchmark strain, with constitutively overexpressed actII orf4.
Moreover, a transcriptome analysis was undertaken for the high-
yielding strain to assess the global extent of deregulation caused by
the replacement of the native actII orf4 promoter. To the best of
our knowledge, this is the first successful application of the SPL
technology in filamentous bacteria for modulation of antibiotic
production. Some of the promoters obtained in this study
underwent further characterization to make them a generally
available tool for tuning of gene expression in Streptomyces spp.
Materials and Methods
All the chemicals used in this study were analytical grade unless
otherwise stated. All solvents were HPLC grade. All the chemicals
and solvents were purchased from Sigma–Aldrich (Steinheim,
Germany). Water (MQ) was purified with a Milli-Q-system
(Millipore, Bradford, MA). Microtiter plates and lids were
obtained from Enzyscreen (Leiden, Netherlands). Bacterial strains
and plasmids are documented in Table S1 in File S1.
Media and growth conditions for strain construction
E. coli cultures were grown at 37uC in Luria Bertani broth [25].
Gentamycin (25 mg ml21) and ampicillin (100 mg ml21) were used
for E. coli DH5a with containing the plasmid pGM160.
Kanamycin (25 mg ml21) and choloramphenicol (25 mg ml21)
were used for E. coli with ET12567/pUZ8002. Nalidixic acid
(20 mg ml21) was used for E. coli. Hygromycin (50 mg ml21) was
used for E. coli with the plasmid pIJ10257 and the actII orf4
overexpression strain of S. coelicolor. Thiostrepton (25 mg ml21) was
used for S. coelicolor.
Mannitol-Soya flour (MS) agar was used for plating S. coelicolor.
2X YT (16 g l21 tryptone, 10 g l21 yeast extract and 10 g l21
sodium chloride) medium was used for germination of spores.
DNA related techniques
DNA techniques involving E. coli were performed as described
by Sambrook et al. (2001) [25]. E. coli transformations were
performed using electroporation. Expand high fidelity Taq
polymerase purchased from Roche diagnostics (Germany) was
applied for PCR intended for cloning. Taq polymerase purchased
from Sigma Aldrich (USA) was applied for analytical purposes.
Chromosomal DNA from S. coelicolor was isolated as described by
Kisser et al. (2000) [26]. S. coelicolor spores were streaked on MS
agar plates to obtain fresh spores. The spores were harvested in
20% glycerol and used for conjugation.
Construction of the actII orf4 overexpression strain
(S. coelicolor oxp-actII orf4)
The gene actII orf4 was amplified using a forward primer with a
NdeI site and a reverse primer with a PacI site (primer sequences
described in Table S2 in File S1) and inserted into the plasmid
pIJ10257. The resulting plasmid pIJ10257_actII orf4 was used to
transform E. coli ET12567/pUZ8002. E. coli containing ET12567
pIJ10257_actII orf4 was then conjugated with S. coelicolor WT, and
the hygromycin-resistant colonies were selected.
Construction of the promoter library
First the upstream region of actII orf 4 gene was amplified from S.
coelicolor genomic DNA using a forward primer, 59-TAGTG-
GATCCGGTGTCCGGCCGTCCGCGTGCCGTCTG -39 with
a BamHI restriction site (underlined) and a reverse primer 59 – TT-
CGTCTTAATTAACTACTGCACATATGTACTTCTAGAG-
CCGTCACAAGCGATCTCCTATTG -39 with a XbaI site
(underlined). Restriction sites for NdeI and PacI (underlined) were
also included in the reverse primer. TheNdeI and PacIwere included
to facilitate the insertion of the actII orf4 gene in the following step.
The PCR product was digested with BamHI and XbaI and inserted
in the plasmid pGM160. This construct was named pGM160_up-
s_actII orf4. A second PCR fragment was generated for the actII orf4
gene using a forward primer, 59- GTCATATGCTTGANNN-
NNTTGAAANNNNNNNNNNNNNNNNNTTATTNNNNNA-
GCTGTACAGGGGACAGCTGGGACACCCAAGGAAGAAG-
GCTGACGTCCGACATGAGATTCAACTTATTGGGACGT-
G-39 bearing a NdeI site, and a reverse primer 59- ATGATTAAT-
TAACTACACGAGCACCTTCTCAC-39 with a PacI site. The
resulting PCR product was digested with NdeI and PacI, and inserted
between the same restriction sites of the previously constructed
plasmid pGM160_ups_actII orf4, containing a 1.126 kb upstream
region of actII orf4 gene, to obtain the plasmid pGM160_SPL. ActII
orf4 is naturally only transcribed in the stationary phase and hence
in order to ensure the stability of the transcript, the leader sequence
of the native gene was replaced with that of a glycolytic gene pgi2
[14,27]. This was done by including the pgi2 leader sequence in the
forward primer (underlined in the primer) for amplification of actII
orf4. Plasmid pGM160_SPL was used to replace the native
promoter of actII orf 4 with the synthetic ones, thus generating the
SPL strains. A scheme representing various steps of the library
construction is included in Figure S1.
The plasmid pGM160_SPL was then transferred into S. coelicolor
through conjugation with E. coli ET12567/pUZ8002. After a
30 hours incubation at 30uC, the conjugation plates were
transferred to 37uC in order to eliminate autonomously replicating
plasmids [28]. The conjugation plates were incubated at 37uC
until visible colonies of S. coelicolor appeared (around 3–4 days).
The colonies with double cross-overs were selected by plating
them for 4–5 generations. Details are mentioned in Figure S2.
The chosen SPL promoters were sequenced using the forward
primer 59-CGATGTCGGCCGGTGGATGTG-39 and the re-
verse primer 59-ACACGTACGTCTGCAGCGTCGTCATG-39.
Frozen mycelium stock preparation for SPL colonies
Frozen mycelium stock was prepared for 200 Streptomyces
colonies chosen for screening (For details see Text S1 in File
S1). Frozen mycelium stocks for S. coelicolor WT strain, S. coelicolor
oxp-actII orf4 and the 11 SPL strains chosen for detailed
physiological characterization were prepared by inoculating spore
stocks prepared as described above, in 50 ml of the 2X YT
medium and grown in 500 ml shake flasks, following the
procedure described by Sohoni et al. (2012) [29].
SPL Streptomyces coelicolor Actinorhodin Production
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Initial characterization of the SPL in minimal medium
The defined minimal medium used for all the cultivations and
characterization of the SPL strains was adapted and modified from
the phosphate limited Evan’s medium (1970). The medium was
prepared as described by Sohoni et al. (2012), details are described
in Text S2 in File S1) [29]. S. coelicolor cultivations in microtiter
plates and shake flasks were performed at 28uC, with 150 rpm
agitation, as described by Sohoni et al. (2012) [29]. 20 ml of each
frozen stock was inoculated in 10 ml of defined minimal medium.
This was then distributed in 24 well microtiter plates with 3 ml
working volume, with one well representing a single cultivation.
All the colonies were inoculated in duplicates. OD450nm was
measured throughout the experiment. After 120 hours, cultivation
was terminated and ACT production, biomass (dry cell weight/
DCW), glucose content, and RED production were measured as
described below.
Detailed characterization of selected SPL strains in
microtiter plates and bioreactors
11 strains were selected for detailed physiological characteriza-
tion in microtiter plates. In addition, ScoSPL20 was characterized
in bioreactors along with the reference strains S. coelicolor WT and
the benchmark production strain oxp-actII orf4. Batch cultivations
in microtiter plates using the minimal medium were performed in
duplicates and as described by Sohoni et al. (2012) [29]. Samples
from microtiter plates were taken at different time points and
analyzed for OD450nm, DCW, RED production, ACT production,
pH and glucose content. Batch cultivations in bioreactors were
performed at 28uC, pH 6.8–6.9, 500 rpm agitation rate and a
1 vvm aeration rate. Applikon bioreactors with 1 l working
volume were used in this study (Applikon Biotechnology,
Schiedam, Netherlands). Minimal medium excluding MOPS
buffer was inoculated with 1 ml of the frozen mycelia stock.
2 M NaOH was used to maintain the pH. An acoustic gas
analyzer was used to monitor the concentrations of CO2 and O2 in
the exhaust gas (1311, Innova Air Tech Instruments A/S. Nærum,
Denmark). Samples taken from bioreactors at different time points
were analyzed for DCW, RED production, ACT production and
glucose content.
Dry cell weight (DCW) analyses
2.2 ml of the fermentation broth were filtered and analyzed as
described by Borodina et al. (2008) [17].
ACT and RED measurements
For ACT production measurements, 100 ml of broth was mixed
with 1.9 ml of 2 M NaOH. For RED production measurements,
100 ml of broth was mixed with 1.9 ml methanol-HCl (pH 1.5).
Measurements were performed as described by Borodina et al.
(2008) [17].
Glucose measurements
HPLC method described by Borodina et al. (2008) was used for
measuring the glucose content in the medium [17].
Determination of promoter expression levels
The xyloglucanase gene (xeg) from Jonesia sp, optimized for
extracellular secretion in S.lividans by Sianidis et al. (2006) [30], was
used as a reporter gene to quantify the expression from the
sequenced synthetic promoters. Synthetic promoters were incor-
porated in front of the xeg gene using a forward primer containing
a XbaI site and a reverse primer with a NcoI site (primer sequences
can be found in Table S3 in File S1). Respective promoter-xeg
products were inserted into the plasmid pGM160 (can also
function as an expression vector when temperature is not raised
above 34uC). The resulting pGM160_promoter_xeg plasmids
were used to transform E. coli ET12567/pUZ8002, which
eventually was conjugated with S. coelicolor. Thiostrepton resistant
colonies were selected.
Frozen mycelia stocks were prepared in microtiter plates for all
the Sco-promoter-xeg colonies as described by Sohoni et al. (2012)
[29]. These were subsequently grown in a modified Evan’s
medium (Text 4), using microtiter plates as described above.
Samples from all the strains were collected at OD450nm 6.0. Xeg
activity was determined as described by Sianidis et al. (2006) [30].
Transcriptome analysis
Transcriptome analysis was performed for the WT strain and
the ScoSPL20 strain in the mid-exponential phase and in the
ACT-producing phase, using custom made Affymetrix chips for S.
coelicolor A3(2). Samples in the mid-exponential phase were
collected after 21 h of growth for the ScoSPL20 strain and after
25 h of growth for the WT strain (for both the strains
corresponding to a dry weight of approximately 0.5 g/L). Samples
in the ACT-producing phase for the ScoSPL20 were collected
after 52 h of growth and for the WT strain after 90 h. Detailed
protocol for sampling, RNA isolation, probe preparation and
hybridization is provided in Text S3 in File S1.
Affymetrix Microarray Suite v5.0 was used to generate the CEL
files of the scanned DNA microarrays [31]. The statistical open
source language R was used to perform data analysis [32]. Data
preprocessing was carried out using the R/affy package [33],
which implements the Robust Multichip Average (RMA) method
by correcting the Perfect Match (PM) probes, performing quantile
normalization [34] and calculating the expression measure by
using median polish. Pair-wise comparisons using moderated t-test
implemented in the R/Limma package were carried out between
the conditions, in order to detect differential transcriptional
regulation [35]. A P-value of 0.05 was chosen as cut-off for
significance and multiple correction was performed according to
the Benjamini and Hochberg methodology [36].
Results
Construction and screening of a SPL for modulation of
ACT production
A SPL was constructed for modulation of ACT synthesis in S.
coelicolor using the native actII orf4 promoter as a target, and
randomizing the regions flanking the consensus sequences. Around
10,000 colonies were screened by visual inspection, and 200
colonies showing a dark blue halo of ACT were selected for further
characterization. For each selected colony, duplicate cultivations
were performed in microtiter plates and biomass, ACT produc-
tion, RED production and glucose content were analyzed after an
120 h incubation. S. coelicolor WT was included in the character-
ization as reference. The final yield of ACT on biomass (g/g) was
chosen as a criterion for comparison of different strains. A broad
span of yields was obtained, spanning both above and below the
WT level (Figure 1). However, some of the selected 200 strains
failed to grow in the minimal medium. The strain denoted
ScoSPL20 had the highest absolute ACT yield, approximately 2.8
times higher than that of the WT strain. ScoSPL20 and an
additional 10 randomly selected SPL strains having higher or
lower yields of ACT on biomass were chosen for a detailed
physiological analysis.
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Further physiological characterization of eleven selected
SPL strains
Of the selected strains, ScoSPL9, ScoSPL20 ScoSPL25,
ScoSPL51, ScoSPL52, ScoSPL110 showed higher yields of
ACT, while ScoSPL7, ScoSPL13, ScoSPL50, ScoSPL117 and
ScoSPL185 showed lower yields of ACT compared to the WT
strain. ScoSPL7, ScoSPL50 and ScoSPL185 did not produce any
ACT up to 120 h of cultivation. The strains were analyzed in in
microtiter plates. The measured parameters included OD450nm,
dry cell weight (g l21), glucose content (g l21), ACT production
(mg l21) and RED production (mg l21). Since this type of
characterization routinely gives very reproducible results in our
experimental setup (within 5% relative error); all measurements
were performed in two, rather than three, biological replicates.
The rates and yields calculated from one replicate for the
characterized SPL strains and the S. coelicolor WT are presented
in Table 1.
All the selected strains grew faster than the WT, except for the
ScoSPL50 which grew at a rate comparable with that of the WT.
Volumetric productivity of ACT (qPACT) and yield of biomass on
substrate (YSX) for the ScoSPL strains were comparable to values
obtained for the WT, except for ScoSPL9 that showed elevated
qPACT (almost double) and ScoSPL20 that showed elevated levels
of both qPACT and YSX. There was a substantial decrease in the
volumetric productivity of RED (qPRED) for all the ScoSPL
strains, except for the ScoSPL20, for which the qPRED was
comparable with that detected for the WT. Interestingly, all
ScoSPL strains that displayed a higher yield of ACT on biomass
(except the ScoSPL20), showed a distinct period in the RED phase
where the biomass was constant, i.e. the growth was stalled for 12–
15 h (data not shown). Among the 11 strains characterized, the
ScoSPL20 was chosen for further analysis in bioreactors as the
most promising one.
Physiological characterization of reference strains in
bioreactors
S. coelicolor WT and S. coelicolor oxp-actII orf4 were used as
reference strains for comparative studies. Physiological character-
ization of the strains was performed in bioreactors in triplicate.
Growth behavior of all the three strains is depicted in figure 2.
Typical growth behavior of the WT strain illustrates four
different phases (Figure 2a), namely: 1) the lag phase (before
sampling starts up to 20 h), 2) the exponential (exp) phase where
the organism grows with maximum specific growth rate, 3) the
RED-production phase or a second growth phase, where RED
production starts and the culture continues to grow but at a
reduced rate, 4) the stationary (stat) phase, where growth almost
Figure 1. Initial screening of Synthetic Promoter Library. Yield of ACT (g/g) on biomass for 200 selected SPL strains at the end of 120 h of
cultivation. S. coelicolor WT strain and S. coelicolor oxp-actII orf4 were used as reference strains. Arrows and numbers on the yield graph indicate the
position of 11 ScoSPL strains that were selected for detailed physiological characterization. Number of experimental replicates: 2.
doi:10.1371/journal.pone.0099701.g001
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stops and production of ACT starts. ACT production continues
until glucose in the medium is exhausted.
Cultivation of the oxp-actII orf4 strain also displayed 4 phases,
but with different properties (Figure 2b). The lag phase was
followed by an exponential phase with maximum specific growth
rate. Since actII orf4 was expressed under a constitutive promoter,
ACT production started already in the exponential phase. The
specific growth rate in this phase (mexp) for oxp-actII orf4 strain
(0.11 h21) was comparable to that of the WT strain (0.10 h21).
Surprisingly, RED production started in parallel with ACT
production in this strain, indicating crosstalk between the two
pathways. We also observed another growth phase with reduced
rate (0.031 h21, 22.5% lower than m for the second phase for the
WT strain). In the stationary phase, the growth almost ceased and
the culture continued to produce RED and ACT. For oxp-actII
orf4 strain, the specific substrate uptake rate (2rS) increased by
26.9%, while the yield, YSX, decreased by 14.5% compared to the
WT strain (Table 2). This effect may be due to the competition for
glucose between the production of biomass and antibiotics. The
volumetric production rate for RED decreased by 60% while, that
of ACT increased by 27.5% in the oxp-actII orf4 strain compared
to the WT strain (Table 2).
Physiological characterization of ScoSPL20
ScoSPL20 also showed 4 distinct growth phases (Figure 2c).
There was no significant change in mexp when compared with the
WT and the oxp-actII orf4 strains. A RED-production phase
followed the exponential growth phase. The specific growth rate in
the RED-production phase was 30% lower than observed for the
WT strain (0.028 and 0.04 h21, respectively) (Table 2). In
addition, the RED-production phase in the ScoSPL20 was almost
12 h shorter than in the WT (Figure 2a and 2c). In the ACT-
production phase, the ScoSPL20 continued to grow with a m of
0.028 hr1, contrary to the WT strain that ceased growing. In the
ScoSPL20 strain, -rS increased by 37% and 10% compared to the
WT and the oxp-actII orf4 strains, respectively. The yield of
biomass on glucose (YSX) decreased by 7.5% compared to the WT
strain. Another marked difference between the S. coelicolor WT and
the ScoSPL20 was the onset of antibiotic production. In the
ScoSPL20, there was an early shift to RED production and from
RED to ACT production compared to the WT strain. However the
antibiotic production did not come as early and in parallel with
growth as observed for the oxp-actII orf4 strain (Figure 2a, 2b and
2c). Volumetric production rate for RED decreased by 29%
compared with the WT strain, while there was a significant
increase in ACT volumetric production rate in the ScoSPL20.
Volumetric production rate of ACT increased by 285% and 257%
compared to the WT and the oxp-actII orf4 strains, respectively
(Table 2).
Transcriptome analysis of the ScoSPL20
Transcriptome analysis was performed in mid-exponential
phase and ACT production phase to compare gene expression
profiles of the ScoSPL20 and the WT strain. Since the two strains
differ in time course of the different growth and production phases,
samples in the ACT phase were not collected at a specific time
point but at a fixed ACT concentration of 100 mg/L i.e. when the
cells were committed to ACT production. Gene expression profiles
were compared intra-strain i.e. exponentially growing WT to
ACT-producing WT and exponentially growing ScoSPL20 to
ACT-producing ScoSPP20; and inter-strain i.e. exponentially
growing WT to exponentially growing ScoSPL20 and ACT-
producing WT to ACT-producing ScoSPL20, at P-value of 0.05.
The genes that were significantly up-regulated or down-regulated
were divided into 10 different groups, of which 9 are represented
in Figure 3. The 10th group, consisting of hypothetical and
putative genes was omitted.
Comparison of exponentially growing WT to ACT-producing
WT transcription profiles resulted in the identification of 299
genes with significant changes in expression, of which 194 were
up-regulated and 105 were down-regulated in the stationary
phase. The genes that were up-regulated included genes for
biosynthesis of ACT (25 genes) and RED (18 genes). Furthermore,
6 genes involved in phosphate metabolism including phoP and phoR
were up-regulated. Genes for glutamate and glutamine synthesis
were down-regulated, while those for nitrate metabolism were up-
regulated. With respect to cofactor metabolism, NADH dehydro-
genase subunits were up-regulated, while cytochromes and ATP
Table 1. Comparative table representing specific growth rate (m), volumetric production rate for AC (qPACT) and volumetric
production rates for undecylprodigiosin (qPRED) represented as mg l
21 h21 and yield of biomass over substrate (YSX) from one of
the two biological replicates.
ScoSPL ID m (h21) qPACT (mg l
21 h21) qPRED (mg l
21 h21) YSX
¤ (g g21)
Sco (WT) 0.11 9.4 1.82 0.32
ScoSPL20 0.14 35.96 1.82 0.27
ScoSPL9 0.12 16.7 0.23 0.26
ScoSPL25 0.15 9.32 0.38 0.36
ScoSPL110 0.13 8.89 0.09 0.13
ScoSPL51 0.14 7.68 0.08 0.22
ScoSPL52 0.13 7.19 0.1 0.2
ScoSPL13 0.15 7.16 0.47 0.24
ScoSPL117 0.12 6.9 0.1 0.26
ScoSPL7 0.14 0 0.31 0.21
ScoSPL50 0.11 0 0.06 0.26
ScoSPL185 0.12 0 0.06 0.26
¤- YSX was calculated in the exponential phase of growth.
doi:10.1371/journal.pone.0099701.t001
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synthase were down-regulated. Thirty genes involved in ribosomal
synthesis and 5 genes involved in central carbon metabolism were
significantly down-regulated in the stationary phase.
Gene expression profile comparison of exponentially growing
ScoSPL20 and ACT-producing ScoSPL20 resulted in detection of
449 genes with significant changes in expression. Of these, 185
genes were up-regulated and 264 genes were down-regulated. 25
genes for ACT biosynthesis and 24 genes for RED biosynthesis
were up-regulated in the stationary phase. In addition, afsR2 and 5
genes for phosphate metabolism were found to be up-regulated. 55
genes connected to ribosomal synthesis and protein synthesis, and
14 genes in central carbon metabolism were significantly down-
regulated. Of the 30 genes significant for cofactor metabolism,
NADH dehydrogenase subunit genes were up-regulated, while
cytochrome and ATP synthase were down-regulated. As for the
WT strain, genes for amino acid metabolism were down-regulated,
while nitrate metabolism genes were up-regulated in the stationary
phase.
Among the hypothetical and putative genes in the comparison
of the exponentially growing WT to ACT-producing WT and the
exponentially growing ScoSPL20 to ACT-producing ScoSPL20,
some genes that were up-regulated are associated with phosphate
metabolism.
Inter-strain comparison of exponentially growing WT and
exponentially growing ScoSPL20 did not yield any genes with
significant expression changes. However, the expression profile
comparison of ACT-producing WT and ACT-producing
ScoSPL20 resulted in 154 genes with significantly different
expression, of which 75 were up-regulated and 79 were down-
regulated (Figure 4) in the ScoSPL20. Of these genes, 15 ACT
biosynthetic genes and 1 RED biosynthetic gene were up-
regulated. 3 genes involved in glutamate metabolism, 3 genes
involved in peroxide breakdown and 14 genes coding for the
NADH dehydrogenase were also up-regulated in the ScoSPL20.
Promoter sequencing and determination of expression
levels
Promoters for the 11 SPL strains that were studied in detail
were sequenced. Table 3 represents sequences of the promoters of
these SPL strains, with the wild type promoter sequence included
for reference. Expression level from these promoters was measured
using the xyloglucanase gene from Jonesia sp. (xeg) as a reporter.
The expression level of different promoters is represented in
Figure 5. A clear correlation between the Xeg activity and the
yield of ACT on biomass was detected for most of the promoters
(Figure 5; Table 2). The native actII orf4 promoter activity was in
between the highest and the lowest values of activities. Surpris-
ingly, the expression level of the ScoSPL20 promoter, which gave
the highest yield of ACT on biomass, was similar to that of the
native actII orf4 promoter. Furthermore the SPL20 promoter also
exhibited some degree of variations with respect to the non-
randomized promoter regions. This sort of variation in predefined
PCR primer sequences often arises during SPL construction due to
errors in the synthesis of such long oligonucleotides.
Discussion
Gene overexpression and gene deletion have been the most
common strategies used in metabolic engineering to improve flux
through a desired pathway. However, these strategies have some
drawbacks. Deletion of a gene leading to an undesired product
may lead to diminished performance, due to its involvement in
some important function in the cell [37]. Overexpression of genes
often leads to excessive burden on the cell [38]. Hence the SPL
concept is attractive in order to tune expression levels for optimal
outcome.
Different approaches have been proposed to improve ACT
production in S. coelicolor. Wang et al. (2008) report increased ACT
production in S. coelicolor by introducing a mutation conferring
drug resistance to streptomycin, rifampin and so on. They report
production of 1.63 g/i ACT in mutants that harbored 7 or 8
mutations that conferred resistance to 7 or 8 antibiotics. [39]. In
Table 2. Comparative table describing physiological parameters of S. coelicolor WT, S. coelicolor oxp-actII orf4 and ScoSPL20.
Results are the mean values with standard deviations from three biological replicates.
Sco (WT) Sco oxp actII orf4 (ermE*) Sco SPL20
m exp phase (h21) 0.160.005 0.1160.001 0.1260.01
m RED phase (h21) 0.0460.01 { 0.0360.01
m Act phase (h21) 0 0 0.0360.002
-rs` (mmol glu g DCW21 h21) 1.860.11 2.360.02 2.560.10
qPACT (mg l
21 h21) 12.460.34 15.860.8 47.764.30
qPRED (mg l
21 h21) 1.960.18 0.860.10 1.560.10
YSX
` (g g21) 0.3160.02 0.2660.01 0.2960.01
{Did not display a defined RED production phase, onset of RED and ACT production was simultaneous and growth associated.
`rS and YSX were calculated in the exponential growth phase.
doi:10.1371/journal.pone.0099701.t002
Figure 2. Batch profile of different strains in minimal medium, using a bioreactor. (A) Batch profile of S. coelicolor A3(2). The graph shows
time course measurement for DCW (&), glucose content in g l21 (N), ACT production (m) and RED production (6) in mg l21. Vertical lines indicate
the onset of RED and ACT production, respectively. Number of experimental replicates: 3. (B) Batch profile of S. coelicolor oxp-actII orf4. The graph
shows time course measurement for DCW (&), glucose content in g l21 (N), ACT production (m) and RED production (6) in mg l21. Vertical line
indicates the onset of RED and ACT production. Number of experimental replicates: 3. (C) Batch profile of ScoSPL20. The graph shows time course
measurement for DCW (&), glucose content in g l21 (N), ACT production (m) and RED production (6) in mg l21. Vertical lines indicate the onset of
RED and ACT production, respectively. Number of experimental replicates: 3.
doi:10.1371/journal.pone.0099701.g002
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another approach, Craney et al. (2012) screened a library of small
chemical compounds that enhance ACT production. ACT
production in this approach increased by up to 5-fold [40] but
final concentration achieved is not reported. In our approach, we
modulated ACT production by randomizing the promoter
sequence of a positive regulator actII orf4 and report ACT
concentration of 3 g/l and i.e. up to 3-fold increase in ACT
production compared to the WT strain. These optimization
Figure 4. Hierarchical clustering (Pearson correlation, average distance) of the genes. Genes with a significant change in expression level
between the WT and the SPL20 strain during the stationary phase. The rows and columns represent genes and samples respectively. The scale of the
color-bar is based on the z-score.
doi:10.1371/journal.pone.0099701.g004
Figure 3. Summary of transcriptome analysis. Categories of genes that are up-regulated or down-regulated in the comparison of gene
expression profiles of the WT and the ScoSPL20 strains in the exponential and stationary phases.
doi:10.1371/journal.pone.0099701.g003
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approaches are not mutually exclusive, and could be combined to
yield a more efficient production strain.
In this study, a SPL defined from 200 colonies displaying
different expression levels was screened for production of ACT
and yield of ACT on biomass. The variability of expression levels
generated by the library does not necessarily correlate only to
different promoter strengths. This approach relies on the ‘‘survival
window’’ to screen against small colonies in which the promoter
negatively affects cell viability. For example, SPLs may contain
some very strong promoters, but if strong overexpression of the
target gene is toxic, these promoters will not give viable cells, and
will be eliminated from the screen. Even for non-toxic proteins, if
the promoter is too strong, and the protein folding capacity of the
cell is not sufficient to match it, this will also result in diminished
protein levels, and loss of correlation between promoter strength
and detectable expression. All SPL colonies that grew on the
minimal medium in microtiter plates contained promoters yielding
viable expression levels of actII orf4. When the 200 selected
colonies were inoculated in the minimal medium, some of the
colonies failed to grow. This could be due to high expression levels
of actII orf4, which had negative effect on the cell growth in the
Table 3. Promoter sequences for selected ScoSPL strains and that of the wild type actII orf4 promoter.
Strain Name Promoter sequence
Synthetic promoter NNNNNTTGAAANNNNNNNNNNNNNNNNNTTATTNNNNN
actII orf4 WT GCACATTGAAATCTGTTGAGTAGGCCTGTTATTGTCGC
ScoSPL7 CGGGCTGGGGCTCGGGGCCGCCGGTGAGCTGGTAGACG
ScoSPL9 GCGGGAGAACTTAACAGCGGGTAGTTCGTAATTTGCAA
ScoSPL13 TGGGGATGAATTAGTTCCGACCCGAATTCTGTTATTCCG
ScoSPL20 TGAGCTGGTAGACGAAGGCGCCCGAGTCTCCTTCGTTC
ScoSPL25 GCTGGTAGACGAAGGCGCCCGAGTCTCCTTCGTTCACTG
ScoSPL50 GAGGTTTGCGAATGTCGCCTTGGTGCCCTTGTTCGTCA
ScoSPL51 CATATTTTGATTATTCTTTTTCTTTTTCTTCTTCTCTG
ScoSPL52 GTGCCTTGTGCTTTGATTGGCTTTATCGTTGTTGTGGC
ScoSPL110 GGCAAGTGTTCAGAGATAAAGGGCTCGGTTATTAGGGA
ScoSPL117 TGCTCGCTGTTTTTTTACGTCTTGGGGATTACTGGAAC
ScoSPL185 TGGCCCCGACCAGGCTCGCTCCCCCATTTTTACCTCGG
doi:10.1371/journal.pone.0099701.t003
Figure 5. Expression levels of different SPL promoters – determined using xeg as reporter gene. WT-ACT refers to the native actII orf4
promoter. Number of experimental replicates: 2.
doi:10.1371/journal.pone.0099701.g005
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minimal medium, where it needs to synthesize all building blocks
for biomass formation de novo.
We selected 11 SPL strains for detailed physiological charac-
terization, promoter sequencing and determination of the expres-
sion level using a reporter gene. These strains showed varied ACT
production, and correspondingly, exhibited different expression
levels i.e. lower and higher than the expression level of the native
actII orf4 promoter. SPLs constructed for S. cerevisiae [19], E. coli
[21], L. lactis [14] and S. lividans [24] also reported broad spectra of
expression from the synthetic promoters (several orders of
magnitude). In those cases, the promoters could be used for
optimizing gene expression of other genes in the same organism or
in the same genus (P.R. Jensen, personal communication).
Among the 11 selected strains, most of those that showed higher
yield of ACT on biomass also demonstrated higher expression
levels of the reporter gene (ScoSPL9, ScoSPL25, ScoSPL51,
ScoSPL52 and ScoSPL110). In these strains, despite the higher
amount of produced ACT, lower final concentration of biomass
was observed, indicating that they underwent stress during growth
(detectable in their growth behavior). The ScoSPL20 promoter
was an exception to the ranking order. It showed similar
expression level of the reporter gene to the WT, but its ACT
yield on biomass was considerably higher. Surprisingly, in the
ScoSPL20 strain ACT production started already in the
exponential growth phase. The ScoSPL20 strain did not seem to
exhibit any stress during growth. We speculate that the stress
recorded in all the SPL strains except for ScoSPL20 may be
related directly (cost of protein synthesis) or indirectly (conse-
quence of deregulation of ActII orf4 target genes) to the burden of
higher expression of actII orf4. Strains with lower yield of ACT on
biomass compared to the WT demonstrated lower expression
levels of the reporter gene and also produced little or no ACT.
In the construction of a generalized promoter library for
Streptomyces spp. Seghezzi et al. (2011) reported a relatively
conserved 235 region, but a considerable variation in the 210
region. Stronger promoters corresponded to enrichment in G
within the promoter sequence [24]. Interestingly, in our case, the
promoter sequencing revealed extensive loss of conservation in
both the 210 and 235 region defined in the primers used for SPL
construction. The ScoSPL20 contained two extra G residues in the
235 region compared to the wild type actII orf4 promoter. This
may reflect the fact that the expression of actII orf4 is incompatible
with the consensus sequences we used, and the library screening
selected mutated promoters that are viable in combination with
the gene actII orf4.
Comparison of gene expression profiles of the WT and the
ScoSPL20 strains demonstrated interesting effects. Intra-strain
comparisons, i.e. exponentially growing WT to ACT-producing
WT and exponentially growing ScoSPL20 to ACT-producing
ScoSPL20 resulted in 299 and 449 differently expressed genes,
respectively. We classified genes in various groups and it was
evident from the comparison of exponentially growing ScoSPL20
to ACT-producing ScoSPL20 that protein synthesis and central
carbon metabolism (glycolysis, PP pathway and TCA cycle) were
substantially reduced in stationary phase as expected. However,
the number of genes down-regulated in both gene classes was
significantly higher in the ScoSPL20 than in the WT. This might
be correlated to the increased glucose uptake rate (2rS) in the
ScoSPL20. Increased glycolytic flux and TCA cycle activity in the
exponential phase due to the increased uptake rate [41] would
result in a more significant difference between exponential and
ACT production phase with regard to down-regulation of these
genes when primary metabolism ceases.
We observed that the RED production was not severely affected
in the ScoSPL20 strain. This is in agreement with the findings in
the S. coelicolor oxp-actII orf4 strain, where we also observed
simultaneous onset of RED and ACT production. This notion is
also supported by the transcriptome analysis. However, our results
are inconsistent with earlier observations of Huang et al. (2005).
They reported a relative decrease in red-independent genes of the
RED cluster as a response to actII orf4 overexpression [42]. Their
studies were based on the R5 agar medium, while we used
phosphate limited liquid minimal medium and the disagreement
may be a result of this difference. We found 25 genes involved in
ACT biosynthesis that were up-regulated in the stationary phase
for both the WT and the ScoSPL20 strain, while 18 and 24 genes
involved in RED biosynthesis were up-regulated in ACT-
producing phase in the WT strain and the ScoSPL20, respectively.
This indicates that overexpression of actII orf4 does not have
negative regulatory effects on RED synthesis.
Comparison of the gene expression profiles of ACT-producing
WT to ACT-producing ScoSPL20 pin-pointed 154 genes that
were differentially expressed in the ScoSPL20. Of these, 15 genes
involved in ACT biosynthesis were up-regulated in the ScoSPL20.
This is coherent with the increased ACT production observed in
the ScoSPL20 compared to the WT strain. In addition, genes
encoding NADH dehydrogenase subunits and genes for glutamate
metabolism were up-regulated in the ScoSPL20 strain. Biosyn-
thesis of ACT requires 12 ATP and 6 NADPH molecules [43].
Hence up-regulation in NADH dehydrogenase and glutamate
metabolism may be connected to requirements for precursors, i.e.
ATP (NADH dehydrogenase) and NADPH (glutamate metabo-
lism) for ACT biosynthesis.
In addition to genes directly involved in antibiotic biosynthesis,
we observed up-regulation of other genes (hypothetical or putative)
that are related to nitrogen and phosphate metabolism when
comparing the expression patterns for exponential and stationary
phase for both strains. Several of these genes have also previously
been shown to be connected to ACT biosynthesis [44,45,46].
They include the alkaline phosphatase SCO2286, and the
glycerophosphoryl diester phosphodiesterase (glpQ) homologs
SCO1968 and SCO7750, as previously observed by Lian et al.,
2008 [44]. For nitrogen metabolism, glnA (SCO2198) that plays a
key role in nitrogen assimilation at low ammonia concentration
was up-regulated in the stationary phase in both strains. Several
other genes with significantly different expression belonged to
nitrogen and phosphate metabolism categories, confirming earlier
reports on interplay between nitrogen and phosphate metabolism
and regulation of ACT biosynthesis [44].
The S. coelicolor oxp-actII orf4 strain that served as a reference
strain in this study contained actII-orf4 expressed under a strong
constitutive promoter. This strain had a decreased biomass yield
and only a slightly elevated ACT productivity compared to the
WT strain, indicating a high burden on the cell. In contrast, the
ScoSPL20 promoter that showed similar activity to the WT
promoter but was expressed earlier in the growth phase, showed
comparable biomass yields as the WT strain while gaining an
almost three-fold higher ACT productivity. This highlights the
utility of fine-tuning of gene expression as an interesting alternative
to overexpression for improving product formation [19].
Supporting Information
Figure S1 Plasmid construction.Different steps carried out in
construction of plasmid pGM160_up_actII orf4 and pGM160_SPL
that are used in construction synthetic promoter library.
(TIF)
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Figure S2 Selection of ScoSPL colonies. Flow chart
describing selection of ScoSPL colonies from conjugation plates.
(TIF)
File S1 Includes detailed protocols to support methods and
materials section. Different primer sequences designed for this
study are also included here.
(DOC)
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